Piezo Therapeutics is developing PIEZO-101, a first‑in‑class regenerative therapy designed to help skin rebuild what aging, inflammation, and damage have taken away. The company conducts clinical trials (e.g., NCT07671027) and shares press releases such as a 2023 announcement on PRWeb. Their mission focuses on reversing skin aging through innovative DNA‑based treatments.
Piezo Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Skin, and Regenerative.
Regulatory Posture applies to this provider. Its tags matched the
Horizontal (data, software, accessibility, platform) regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Show this score on your site.
It updates itself when the score changes. Paste this where you link to your API docs:
<a href="https://apis.io/providers/piezo-therapeutics/"><img src="https://apis.io/badge/piezo-therapeutics/card.svg" alt="Piezo Therapeutics on APIs.io — Kin Score by API Evangelist"></a>
Other styles, a README pill and a shields.io endpoint are on the badge page.
Raise your score.
Agent readiness — checks not met, largest first (exact, from this profile):
Machine-Readable Auth+10 pts — a served openid-configuration/oauth-authorization-server carrying `issuer` (served), else the securitySchemes class in the provider OpenAPIs — bound (mutualTLS, DPoP, Signature) > negotiable (oauth2 authorizationCode/clientCredentials, openIdConnect) > bearer (http bearer, apiKey)
Idempotency+9 pts — OpenAPI mutating operations declare an idempotency key — a header, a request-body property, or a named de-duplication token whose own description says so (verified); else common[].type matches /idempoten/i (documented)
A2A Agent Card+8 pts — a2a/-a2a.yml manifest, graded on conformance.grade against A2A 1.0.0
12 more unmet checks in the Agent Readiness table above.
Kin Score — facets with the most composite points still available (weight × headroom):
aid: piezo-therapeutics
name: Piezo Therapeutics
description: Piezo Therapeutics is developing PIEZO-101, a first‑in‑class regenerative therapy designed to help skin rebuild
what aging, inflammation, and damage have taken away. The company conducts clinical trials (e.g., NCT07671027) and shares
press releases such as a 2023 announcement on PRWeb. Their mission focuses on reversing skin aging through innovative DNA‑based
treatments.
url: https://artifacts.apis.io/piezo-therapeutics/apis.yml
image: https://piezotx.com/assets/logo-header-light.svg
x-type: company
x-source: harvest:vc-portfolio
x-tier: profiled
x-tier-reason: enrichment pass 2026-10-29 (modular-v1; was harvest)
specificationVersion: '0.20'
created: '2026-10-29'
modified: '2026-10-29'
tags:
- Company
- Biotechnology
- Therapeutics
- Skin
- Regenerative
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Hosts
url: hosts/piezo-therapeutics-hosts.yml
- type: Vendors
url: vendors/piezo-therapeutics-vendors.yml
- type: DomainSecurity
url: security/piezo-therapeutics-domain-security.yml
- type: Website
url: https://piezotx.com
- type: Press
url: https://www.prweb.com/releases/piezo-therapeutics-launches-to-transform-delivery-of-nucleic-acid-medicines-884236950.html
apis: []
x-backed-by:
- true-ventures
x-coverage:
state: none
reason: not-a-software-company
detail: Piezo Therapeutics is a biotechnology company that does not expose a public API.
evidence:
- url: https://api.piezotx.com
status: 0
checked: '2026-10-29'
x-enrichment:
date: '2026-10-29'
status: enriched
artifacts_added: 19
pass: modular-v1
engine: identity=oss,contract=oss,surfaces=oss,docs=oss,regulatory=oss
Piezo Therapeutics API — frequently asked questions
How do I authenticate with the Piezo Therapeutics API?
Piezo Therapeutics documents its authentication (0 schemes). The details are profiled on APIs.io as Piezo Therapeutics Authentication.
Is the Piezo Therapeutics API ready for AI agents?
Piezo Therapeutics has a Kin Score of 5.1 out of 100 (minimal) and an Agent Readiness score of 2.5 (human-only), scored by API Evangelist on 2026-10-31.
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.